CervoMed Inc. (CRVO) income statement
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.33−0.12 (-8.28%)
Close on Nov 19, 2026Market cap $20.11MP/E –Yield –
CervoMed Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -9407.0%
- Net margin
- -9160.9%
- Return on equity, FY2025
- -93.9%
Financial strength
- Current ratio
- –
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- 60.70
- Price to book
- 0.88
- Dividend yield
- –
See a number that looks wrong?